Description: JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Home Page: www.jw-pharma.co.kr
2477, Nambusunhwan-ro
Seoul,
137-864
South Korea
Phone:
82 2 840 6777
Officers
| Name | Title |
|---|---|
| Mr. Young-Sub Shin | CEO, Head of Sales & Marketing and Inside Director |
| Sung-Yeol Lee | CEO, Head of Product Devel. & Management and Director |
| Bum-Jin Yoon | Head Managing Director and Head of Bus. Planning Division |
| Mr. Jung-Ho Kim | Head of Pharmaceutical Division and Sr. Managing Director |
| Jae-Kwang Jeon | Head Managing Director and Head of Public Relation |
| Seung-Ho Choi | Head Managing Director and Head of Material Composition |
| Bong-Sik Kim | Head Managing Director and Head of Medical Division |
| Se-Moon Oh | Head of Diagnostic Division and Managing Director |
| Jong-Hyun Yoo | Head of Health Care Division and Managing Director |
| Mi-Kyung Han | Managing Director and Head of Research Center |
Exchange: KO
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.1139 |
| Price-to-Sales TTM: | 0.6646 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1127 |